Olaplex Holdings Inc.‘s $47.5 million settlement earned a judge’s final approval to end allegations that its initial public offering documents didn’t disclose the European Union banned an ingredient formerly used in one of its products.
Judge
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.